Other Cancers ICARIA-MM: Isatuximab + Pomalidomide vs Pomalidomide in R/R Multiple Myeloma Jun 30, 2023
Genitourinary Cancer,Prostate Cancer Cabozantinib Plus Atezolizumab in mCRCPC: Results From COSMIC-021 Trial Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Durvalumab Treatment and Real-World Survival in Stage III NSCLC: PACIFIC-R Trial Jun 30, 2023
Colorectal Cancer,Gastrointestinal Cancer FTD/TPI Combinations in Refractory mCRC: SUNLIGHT Phase III Jun 30, 2023
Other Cancers NIVO+Chemo/IPI vs. Chemo in 1L Advanced ESCC - Expanded Efficacy and Safety Analyses Jun 30, 2023
Other Cancers Pembrolizumab Combination Therapy in Metastatic Squamous NSCLC: KEYNOTE-407 Jun 30, 2023
Breast Cancer,HER2-,TNBC (Triple Negative Breast Cancer) Interim Analysis of Phase III SASCIA Trial on SG in High-Risk HER2-Negative BC Jun 30, 2023
Lymphoma,Other Cancers Liso-cel in Relapsed/Refractory LBCL: Correlation of Expansion, Efficacy, and Safety Jun 30, 2023
